Skip to content

Clinical trials

Subarachnoid Hemorrhage trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Subarachnoid Hemorrhage Phase: Not applicable Clear all

130 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20062
20071
20084
20094
20101
20112
20122
20137
20148
20155
20163
20178
20188
20193
202011
20219
20225
20239
202417
20258
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Unknown status34
Recruiting17
Not yet recruiting13
Terminated11
Withdrawn5
Active, not recruiting3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital9
National Taiwan University Hospital3
Rigshospitalet, Denmark3
Assistance Publique - Hôpitaux de Paris2
First Affiliated Hospital Xi'an Jiaotong University2
Hamad Medical Corporation2
HeadSense Medical2
Insel Gruppe AG, University Hospital Bern2
Minnetronix2
NeMoDevices AG2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Subarachnoid Hemorrhage130
Vasospasm, Intracranial23
Brain Injuries, Traumatic18
Brain Injuries12
Intracranial Aneurysm11
Aneurysm10
Cerebral Hemorrhage7
Hydrocephalus7
Brain Neoplasms5
Intracranial Hypertension5

Trials

Showing 1 to 25 of 130. Each trial links to its page on Pharma Observatory.

30 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.